Answers are grounded in this paper and cite their sources.
Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. Furthermore, it seems that the risk of MACE increased with increasing cumulative or daily dose of GCs.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: